XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net income $ 9,064 $ 78,770
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 47,032 36,347
Amortization of debt issuance costs 1,056 1,016
Equity-based compensation expense 8,677 8,678
Deferred income taxes (5,621) 17,476
Debt extinguishment costs 1,269  
Legal settlements expense 3,504  
Other 73 (4,094)
Change in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable, net (30,993) (22,930)
Other current assets (9,019) (15,629)
Other assets (1,214) 696
Accounts payable and other accrued liabilities (9,242) (403,340)
Accrued salaries and benefits (19,801) (25,024)
Other liabilities 16,692 6,749
Net cash provided by (used in) operating activities 11,477 (321,285)
Investing activities:    
Cash paid for acquisitions, net of cash acquired (8,594) (50,353)
Cash paid for capital expenditures (174,631) (142,410)
Proceeds from sale of property and equipment 43 9,056
Other (56) (907)
Net cash used in investing activities (183,238) (184,614)
Financing activities:    
Borrowings on long-term debt 1,200,000 350,000
Principal payments on revolving credit facility (1,035,000) (15,000)
Principal payments on long-term debt   (10,242)
Repayment of long-term debt (670,856)  
Payment of debt issuance costs (18,615) (1,518)
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (1,936) (1,013)
Repurchase of common stock (46,880)  
Contributions from noncontrolling partners in joint ventures   2,280
Distributions to noncontrolling partners in joint ventures   (1,020)
Other (21) (358)
Net cash provided by financing activities 186,692 483,129
Net increase (decrease) in cash and cash equivalents 14,931 (22,770)
Cash and cash equivalents at beginning of the period 76,305 100,073
Cash and cash equivalents at end of the period 91,236 77,303
Effect of acquisitions:    
Assets acquired, excluding cash 19,768 55,309
Liabilities assumed (300) (3,456)
Contingent consideration issued in connection with an acquisition   (1,500)
Redeemable noncontrolling interest resulting from an acquisition (10,874)  
Cash paid for acquisitions, net of cash acquired 8,594 50,353
New Credit Facility [Member]    
Financing activities:    
Borrowings on revolving credit facility $ 760,000 $ 160,000